Market Research Consumer Goods Market Research Consumer Goods & Retailing Market Research Retailing Market Research E-Commerce & Online Retailing Market Research

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023

Best Price Guarantee Length Publisher Published Date SKU
from $5,000 142 Pages Kalorama Information June, 2023 KLI18014720
Best Price Guarantee
Price from $5,000
Length 142 Pages
Publisher Kalorama Information
Published Date June, 2023
SKU KLI18014720

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023


This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods.

Meanwhile, the global Home IVD testing market is a growing market with much potential. The Home Collection IVD testing market is comprised of testing kits that are obtained from the local pharmacy or internet and sent to the patient's home. The patient collects the specimen, puts it into a collection container and sends it to the laboratory for testing. Results are sent back to the patient and/or referring physician.

This report covers the At-Home and Home testing markets by segmenting them into several broad areas including:
  • Cholesterol
  • Drugs of Abuse
  • Fecal Occult Blood
  • Glucose/ HbA1c including CGM
  • Infectious Disease
* COVID-19 / + Flu + RSV
* HIV
  • Pregnancy and Fertility
  • Rapid Coagulation
  • Genetic (excluding ancestry genetic testing)
The base year for data featured in the report was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2022. The forecasted market analysis for 2022-2027 was largely based on demographic trends, new developments, innovative technology and global expansion.


  • Executive Summary
    • Industry at a Glance
    • Scope and Methodology
    • Size and Growth of the Market
      • Table Global Home IVD Market, by Key Segment (Glucose/HbA1c, COVID-19, Other, Genetic), 2019-2022
    • Key Issues and Trends Affecting the Market
    • Competitive Outlook
    • Conclusion Highlights
  • Introduction
    • Overview
    • Issues and Trends
      • COVID-19
        • Table Home COVID-19 Test Distribution of Sales by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Siemens Healthineers, Quidel, Others)
      • Insurance for Home Tests
        • Table Diabetes State Mandates - State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage
      • Home IVD Testing Drivers and Challenges
        • Table Benefits to Home Testing vs. Challenges in Home Testing
    • Genetics
      • Table Home Genetic Laboratory Testing, Market Drivers and Barriers
    • Home Collection
  • At-Home IVD Tests
    • Introduction
      • Diabetes
        • Table Selected Glucose At-Home Testing Meter Innovations
      • Pregnancy and Fertility
      • Infectious Disease
        • Table Selected COVID- 19 and COVID-19 & Flu A/B At-Home Tests for SARS-CoV-2
      • Coagulation
      • Fecal Occult Blood
      • Cholesterol
      • Drugs of Abuse
    • At-Home IVD Test Market by Test Type
      • Table Global At-Home IVD Market by Test Type (Glucose, Infectious Disease, Other), 2022 ($BN)
      • Table Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19+, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2022
    • At-Home IVD Tests Market by Sample Type
      • Table Global At-Home IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
      • Table Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
      • Table Year-over-Year Growth for At-Home IVD Markets (Cholesterol, Coagulation, COVID-19, Drugs of Abuse, FOB, Glucose, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
      • Table Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Coagulation, Glucose, Other), 2022 (%)
      • Table Estimated Distribution of Urine Sample Sales, by Test Type (Drug of Abuse, Infectious Disease, Pregnancy, Other), 2022 (%)
      • Table Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, HIV, Other), 2022 (%)
      • Table Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
      • Table Estimated Distribution of Stool Sample Sales by Test Type (FOB, Other), 2022 (%)
  • Home Collection IVD Tests
    • Introduction
      • Pregnancy and Fertility
      • Infectious Disease
        • Table Selected Molecular EUA Tests for COVID-19
      • Fecal Occult Blood
      • Cholesterol
      • Genetics
    • Home Collection IVD Tests by Test Type
      • Table Global Home Collection IVD Market by Test Type (Genetics, Infectious Disease, Other Areas), 2022 ($BN)
      • Table Global Home IVD Market by Distribution of Sales by Segment (Cholesterol, Coagulation, COVID-19, Drug of Abuse, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2022 (%)
      • Privacy
    • Home Collection Tests by Sample Type
      • Table Global Home Collection IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
      • Table Global Home Collection IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
      • Table Year-over-Year Growth for Home Collection IVD Markets, by Type (Cholesterol, Coagulation, COVID-19, Drug of Abuse, FOB, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
      • Table Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Fertility, Genetic, Glucose/HbA1c, Infectious Disease - STD blood spot, Tumor Market - PSA blood spot, Other - hormone), 2022 (%)
      • Table Estimated Distribution of Urine Sample Sales by Test Type (Infectious Disease - STD, Pregnancy/Fertility, Other - Heavy metals, hormone, nutrition), 2022 (%)
      • Table Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, Fertility, Genetic, HIV, Other - hormone, nutrition, medication match), 2022 (%)
      • Table Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
      • Table Estimated Distribution of Stool Sample Sales by Test Type (FOB, Infectious Disease – pathogen ID, Other - Heavy metals), 2022 (%)
  • Market Participants
    • 23andMe, Inc
      • Table 23andMe Corporate Summary
      • Company Overview
        • Table 23andMe Genetic Tests with FDA Marketing Authorization
      • Performance Review
        • Table 23andMe Revenue, 2020-2022 ($ millions)
    • Abbott Diagnostics
      • Table Corporate Summary
      • Company Overview
      • Performance Review
        • Table Abbott Revenues, 2020-2022 (in millions $)
    • AccessBio, Inc.
      • Table AccessBio Corporate Summary
      • Company Overview
    • ACON Laboratories, Inc.
      • Table ACON Laboratories Corporate Summary
      • Company Overview
    • ARKRAY, Inc.
      • Table ARKRAY Corporate Summary
      • Company Overview
    • Ascensia Diabetes Care Holdings AG
      • Table Ascensia Diabetes Care Corporate Summary
      • Company Overview
    • Atomo Diagnostics
      • Table Atomo Corporate Summary
      • Company Overview
      • Performance Review
        • Table Atomo Revenues, 2021-2022 (in millions $)
    • Becton-Dickinson
      • Table Becton-Dickinson Corporate Summary
      • Company Overview
      • Performance Review
        • Table BD Corporation Revenue, 2020-2022 ($ millions)
    • binx health
      • Table binx health Corporate Summary
      • Company Overview
    • Biomerica, Inc.
      • Table Biomerica Corporate Summary
      • Company Overview
      • Company Financials
        • Table Biomerica Corporation Revenue, 2020-2022 ($ millions)
    • Biosynex SA
      • Table Biosynex Corporate Summary
      • Company Overview
      • Performance Review
        • Table Biosynex Revenues 2021-2022 (in millions $)
    • BTNX Inc.
      • Table BTNX Corporate Summary
      • Company Overview
    • Church & Dwight Co. Inc
      • Table Church & Dwight Corporate Summary
      • Company Overview
      • Performance Review
        • Table Church and Dwight Revenues, 2020-2022 ($ millions)
    • Color Health, Inc.
      • Table Color Health Corporate Summary
      • Company Overview
    • Cue Health
      • Table Cue Health Corporate Summary
      • Company Overview
    • Dexcom, Inc.
      • Table Dexcom Corporation Corporate Summary
      • Company Overview
      • Performance Review
        • Table Dexcom Revenues, 2020-2022 ($ millions)
    • EasyDNA
      • Table EasyDNA Corporate Summary
      • Company Overview
    • Everlywell
      • Table Everlywell Corporate Summary
      • Company Overview
    • Exact Sciences
      • Table Exact Sciences Corporate Summary
      • Company Overview
      • Performance Review
        • Table Exact Sciences Revenues, 2020-2022 ($ millions)
    • First Check Diagnostics LLC
      • Table First Check Diagnostics Corporate Summary
      • Company Overview
    • GlysBy diagnostics
      • Table GlysBy Corporate Summary
      • Company Overview
    • Helena Laboratories
      • Table Helena Laboratories Corporate Summary
      • Company Overview
    • Hemosure, Inc.
      • Table Hemosure Corporate Summary
      • Company Overview
    • LifeScan, Inc
      • Table LifeScan Corporate Summary
      • Company Overview
    • Medichecks.com Ltd.
      • Table Medichecks Corporate Summary
      • Company Overview
    • Myriad Genetics, Inc.
      • Table Myriad Genetics Corporate Summary
      • Company Overview
      • Performance Review
        • Table Myriad Diagnostics Revenue, 2020-2022 ($ millions)
    • OraSure Technologies, Inc.
      • Table OraSure Technologies Summary
      • Company Overview
      • Performance Review
        • Table OraSure Revenues, 2020-2022 ($ millions)
    • Polymedco, Inc
      • Table Polymedco Corporate Summary
      • Company Overview
    • Preventis GmbH
      • Table Preventis Corporate Summary
      • Company Overview
    • Prima Lab SA
      • Table Prima Corporate Summary
      • Company Overview
    • QuidelOrtho Corporation
      • Table QuidelOrtho Corporate Summary
      • Company Overview
      • Performance Review
        • Table QuidelOrtho Revenues, 2020-2022 ($ millions)
    • Roche Diagnostic Corporation
      • Table Roche Diagnostic Corporate Summary
      • Company Overview
      • Performance Review
        • Table Roche Diagnostics, 2020-2022 ($ millions)
    • Siemens Healthineers GmbH
      • Table Siemens Healthineers Corporate Summary
      • Company Overview
      • Performance Review
        • Table Siemens Healthineers, 2020-2022 ($ millions)
    • Swiss Precision Diagnostics GmbH
      • Table Swiss Precision Diagnostics Corporate Summary
      • Company Overview
    • Trividia Health
      • Table Trividia Health Corporate Summary
      • Company Overview
    • VedaLab
      • Table VedaLab Corporate Summary
      • Company Overview
  • Market Analysis
    • Market Overview
      • Table Global Home IVD Market, 2022-2027, 5% CAGR, ($MN)
    • Market Segment by Test Type
      • Table Global Home IVD Market by Test Type (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2019-2022 ($MN)
      • Table Global Home IVD Market, by General Test Segment (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2022
      • Glucose & HbA1c
        • Table Estimated Global Home IVD Glucose & HbA1c Testing Market, 2022-2027 $MN; CAGR 22-27
      • Infectious Disease
        • Table Estimated Global Home IVD Infectious Disease Testing Market, 2022-2027 $MN; CAGR 22-27
      • Other Areas
        • Table Estimated Global Home IVD Other Testing Market, 2022-2027 $MN; CAGR 22-27
      • Genetic
        • Table Estimated Global Home IVD Genetic Testing Market, 2022-2027 $MN; CAGR 22-27
    • Market by Distribution
    • Market by Region
      • Table Estimated Global Home IVD Testing Market, by Region (APAC, EMEA, United States, Rest of World), 2019-2022
    • Competitive Analysis
      • Table Estimated Global Home IVD Testing Market, Vendor Market Share, by Top Five Market Vendors (Abbott, Dexcom, QuidelOrtho, Roche, Siemens Healthineers, Other), 2022

$5,000
$7,500
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings